Literature DB >> 1463273

Biosynthesis, maturation, release, and degradation of neurotensin and neuromedin N.

P Kitabgi1, F De Nadai, C Rovère, J N Bidard.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1463273     DOI： 10.1111/j.1749-6632.1992.tb27337.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN： 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  8 in total

Review 1.  Prohormone convertases differentially process pro-neurotensin/neuromedin N in tissues and cell lines.

Authors:  Patrick Kitabgi
Journal:  J Mol Med (Berl)       Date:  2006-05-11       Impact factor: 4.599

2.  Modifications at Arg and Ile Give Neurotensin(8-13) Derivatives with High Stability and Retained NTS1 Receptor Affinity.

Authors:  Lisa Schindler; Günther Bernhardt; Max Keller
Journal:  ACS Med Chem Lett       Date:  2019-05-10       Impact factor: 4.345

3.  A stable neurotensin-based radiopharmaceutical for targeted imaging and therapy of neurotensin receptor-positive tumours.

Authors:  Elisa García-Garayoa; Peter Bläuenstein; Alain Blanc; Veronique Maes; Dirk Tourwé; P August Schubiger
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-08-09       Impact factor: 9.236

4.  [99mTc]Demotensin 5 and 6 in the NTS1-R-targeted imaging of tumours: synthesis and preclinical results.

Authors:  Theodosia Maina; Anastasia Nikolopoulou; Eleni Stathopoulou; Athanassios S Galanis; Paul Cordopatis; Berthold A Nock
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-06-27       Impact factor: 9.236

5.  Evaluation of DOTA-chelated neurotensin analogs with spacer-enhanced biological performance for neurotensin-receptor-1-positive tumor targeting.

Authors:  Yinnong Jia; Wen Shi; Zhengyuan Zhou; Nilesh K Wagh; Wei Fan; Susan K Brusnahan; Jered C Garrison
Journal:  Nucl Med Biol       Date:  2015-07-29       Impact factor: 2.408

6.  Endogenous CNS expression of neurotensin and neurotensin receptors is altered during the postpartum period in outbred mice.

Authors:  Terri M Driessen; Changjiu Zhao; Anna Whittlinger; Horecia Williams; Stephen C Gammie
Journal:  PLoS One       Date:  2014-01-08       Impact factor: 3.240

7.  Linked production of pyroglutamate-modified proteins via self-cleavage of fusion tags with TEV protease and autonomous N-terminal cyclization with glutaminyl cyclase in vivo.

Authors:  Yan-Ping Shih; Chi-Chi Chou; Yi-Ling Chen; Kai-Fa Huang; Andrew H-J Wang
Journal:  PLoS One       Date:  2014-04-14       Impact factor: 3.240

8.  Optimizing the Profile of [99mTc]Tc-NT(7-13) Tracers in Pancreatic Cancer Models by Means of Protease Inhibitors.

Authors:  Panagiotis Kanellopoulos; Berthold A Nock; Eric P Krenning; Theodosia Maina
Journal:  Int J Mol Sci       Date:  2020-10-26       Impact factor: 5.923
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.